Who to call at Lyell Immunopharma, Inc., and when
Fundz watches for the moments Lyell Immunopharma, Inc. starts buying, and tells you who to reach.
- An alert the day Lyell Immunopharma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lyell Immunopharma, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lyell Immunopharma, Inc.. With Fundz connected, it knows.
Lyell Immunopharma, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
lyell.com2 executive changes at Lyell Immunopharma in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Lyell Immunopharma appointed CEO Lynn Seely, M.D., as interim principal financial officer and promoted Veronica Sanchez Bulis from Vice President, Corporate Controller to principal accounting officer, both effective October 31, 2025. The filing discloses no departure, but the CEO now holds the CFO-equivalent role on an interim basis, which is a notable change in finance leadership.
Key Takeaways
On October 31, 2025, the Board appointed CEO and director Lynn Seely, M.D., as interim principal financial officer, so the chief executive now also holds the principal financial officer role on an int
Veronica Sanchez Bulis, previously Vice President, Corporate Controller, was appointed principal accounting officer, placing the company's senior accounting function under a newly designated officer.
2 more takeaways
Related Filings (3)
3 more filings from Lyell Immunopharma, Inc. in the last 90 days
Filing Overview
What This Means
Lyell Immunopharma, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.